156 related articles for article (PubMed ID: 11693760)
1. Preprocedural C-reactive protein levels and cardiovascular events after coronary stent implantation.
Walter DH; Fichtlscherer S; Sellwig M; Auch-Schwelk W; Schächinger V; Zeiher AM
J Am Coll Cardiol; 2001 Mar; 37(3):839-46. PubMed ID: 11693760
[TBL] [Abstract][Full Text] [Related]
2. Prognostic impact of preprocedural C reactive protein levels on 6-month angiographic and 1-year clinical outcomes after drug-eluting stent implantation.
Park DW; Lee CW; Yun SC; Kim YH; Hong MK; Kim JJ; Park SW; Park SJ
Heart; 2007 Sep; 93(9):1087-92. PubMed ID: 17309906
[TBL] [Abstract][Full Text] [Related]
3. Preprocedural C-reactive protein is not associated with angiographic restenosis or target lesion revascularization after coronary artery stent placement.
Rittersma SZ; de Winter RJ; Koch KT; Schotborgh CE; Bax M; Heyde GS; van Straalen JP; Mulder KJ; Tijssen JG; Sanders GT; Piek JJ
Clin Chem; 2004 Sep; 50(9):1589-96. PubMed ID: 15205368
[TBL] [Abstract][Full Text] [Related]
4. Prognostic values of C-reactive protein levels on clinical outcome after implantation of sirolimus-eluting stents in patients on hemodialysis.
Ishii H; Toriyama T; Aoyama T; Takahashi H; Amano T; Hayashi M; Tanaka M; Kawamura Y; Yasuda Y; Yuzawa Y; Maruyama S; Matsuo S; Matsubara T; Murohara T
Circ Cardiovasc Interv; 2009 Dec; 2(6):513-8. PubMed ID: 20031768
[TBL] [Abstract][Full Text] [Related]
5. Inflammatory response after intervention assessed by serial C-reactive protein measurements correlates with restenosis in patients treated with coronary stenting.
Dibra A; Mehilli J; Braun S; Hadamitzky M; Baum H; Dirschinger J; Schühlen H; Schömig A; Kastrati A
Am Heart J; 2005 Aug; 150(2):344-50. PubMed ID: 16086941
[TBL] [Abstract][Full Text] [Related]
6. Long-term prognostic value of preprocedural C-reactive protein after drug-eluting stent implantation.
Delhaye C; Maluenda G; Wakabayashi K; Ben-Dor I; Lemesle G; Collins SD; Syed AI; Torguson R; Kaneshige K; Xue Z; Suddath WO; Satler LF; Kent KM; Lindsay J; Pichard AD; Waksman R
Am J Cardiol; 2010 Mar; 105(6):826-32. PubMed ID: 20211326
[TBL] [Abstract][Full Text] [Related]
7. Predictive value of preintervention C-reactive protein on clinical outcome after directional coronary atherectomy followed by stent implantation.
Niccoli G; Ferrante G; Mongiardo R; Perfetti M; Belloni F; Burzotta F; Porto I; Leone AM; Rebuzzi AG; Crea F
Cardiovasc Revasc Med; 2007; 8(3):156-60. PubMed ID: 17765643
[TBL] [Abstract][Full Text] [Related]
8. Plasma levels of C-reactive protein and interleukin-10 predict late coronary in-stent restenosis 6 months after elective stenting.
Zurakowski A; Wojakowski W; Dzielski T; Milewski K; Gościńska-Bis K; Tendera M; Buszman P
Kardiol Pol; 2009 Jun; 67(6):623-30. PubMed ID: 19618318
[TBL] [Abstract][Full Text] [Related]
9. Usefulness of the neutrophil-to-lymphocyte ratio to predict bare-metal stent restenosis.
Turak O; Ozcan F; Isleyen A; Tok D; Sokmen E; Buyukkaya E; Aydogdu S; Akpek M; Kaya MG
Am J Cardiol; 2012 Nov; 110(10):1405-10. PubMed ID: 22858185
[TBL] [Abstract][Full Text] [Related]
10. Preprocedural high-sensitivity C-reactive protein predicts death or myocardial infarction but not target vessel revascularization or stent thrombosis after percutaneous coronary intervention.
Delhaye C; Sudre A; Lemesle G; Maréchaux S; Broucqsault D; Hennache B; Bauters C; Lablanche JM
Cardiovasc Revasc Med; 2009; 10(3):144-50. PubMed ID: 19595394
[TBL] [Abstract][Full Text] [Related]
11. Predictive value of preprocedural fibrinogen concerning coronary stenting.
Otsuka M; Hayashi Y; Ueda H; Imazu M; Kohno N
Atherosclerosis; 2002 Oct; 164(2):371-8. PubMed ID: 12204810
[TBL] [Abstract][Full Text] [Related]
12. Usefulness of the platelet-to-lymphocyte ratio in predicting bare-metal stent restenosis.
Yılmaz S; Sen F; Ünal S; Yayla C; Özeke Ö; Aras D; Topaloglu S; Aydogdu S
Scand Cardiovasc J; 2015 Feb; 49(1):39-44. PubMed ID: 25414124
[TBL] [Abstract][Full Text] [Related]
13. Usefulness of preprocedural serum uric acid level to predict restenosis of bare metal stents.
Turak O; Canpolat U; Özcan F; Mendi MA; Oksüz F; Işleyen A; Gürel OM; Çay S; Aras D; Aydoğdu S
Am J Cardiol; 2014 Jan; 113(2):197-202. PubMed ID: 24157191
[TBL] [Abstract][Full Text] [Related]
14. Immunosuppressive Therapy for the Prevention of Restenosis after Coronary Artery Stent Implantation (IMPRESS Study).
Versaci F; Gaspardone A; Tomai F; Ribichini F; Russo P; Proietti I; Ghini AS; Ferrero V; Chiariello L; Gioffrè PA; Romeo F; Crea F;
J Am Coll Cardiol; 2002 Dec; 40(11):1935-42. PubMed ID: 12475452
[TBL] [Abstract][Full Text] [Related]
15. One month follow-up C-reactive protein may be a useful predictor of angiographic restenosis and long-term clinical outcomes after bare metal stent implantation.
Hahn JY; Kim HS; Koo BK; Na SH; Chung JW; Youn TJ; Chung WY; Chae IH; Choi DJ; Oh BH; Lee MM; Park YB
Int J Cardiol; 2006 May; 109(2):267-9. PubMed ID: 16644391
[TBL] [Abstract][Full Text] [Related]
16. Statin therapy, inflammation and recurrent coronary events in patients following coronary stent implantation.
Walter DH; Fichtlscherer S; Britten MB; Rosin P; Auch-Schwelk W; Schächinger V; Zeiher AM
J Am Coll Cardiol; 2001 Dec; 38(7):2006-12. PubMed ID: 11738308
[TBL] [Abstract][Full Text] [Related]
17. Elevated preprocedural high-sensitivity C-reactive protein levels are associated with neointimal hyperplasia and restenosis development after successful coronary artery stenting.
Hong YJ; Jeong MH; Lim SY; Lee SR; Kim KH; Sohn IS; Park HW; Kim JH; Kim W; Ahn Y; Cho JG; Park JC; Kang JC
Circ J; 2005 Dec; 69(12):1477-83. PubMed ID: 16308495
[TBL] [Abstract][Full Text] [Related]
18. Association between C-reactive protein and angiographic restenosis after bare metal stents: an updated and comprehensive meta-analysis of 2747 patients.
Ferrante G; Niccoli G; Biasucci LM; Liuzzo G; Burzotta F; Galiuto L; Trani C; Rebuzzi AG; Crea F
Cardiovasc Revasc Med; 2008; 9(3):156-65. PubMed ID: 18606379
[TBL] [Abstract][Full Text] [Related]
19. C-Reactive protein, clinical outcome, and restenosis rates after implantation of different drug-eluting stents.
Gaspardone A; Versaci F; Tomai F; Citone C; Proietti I; Gioffrè G; Skossyreva O
Am J Cardiol; 2006 May; 97(9):1311-6. PubMed ID: 16635602
[TBL] [Abstract][Full Text] [Related]
20. Usefulness of preprocedural levels of advanced glycation end products to predict restenosis in patients with controlled diabetes mellitus undergoing drug-eluting stent implantation for stable angina pectoris (from the Prospective ARMYDA-AGEs Study).
Spadaccio C; Patti G; De Marco F; Coccia R; Di Domenico F; Pollari F; Zanzonico R; Pettinari M; Lusini M; Di Sciascio G; Covino E; Chello M
Am J Cardiol; 2013 Jul; 112(1):21-6. PubMed ID: 23561587
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
